- Home
- IMTX vs BDN Comparison
IMTX vs BDN Comparison
Compare IMTX & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- BDN
- Stock Information
- Founded
- IMTX N/A
- BDN 1986
- Country
- IMTX Germany
- BDN United States
- Employees
- IMTX N/A
- BDN N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- BDN Real Estate Investment Trusts
- Sector
- IMTX Health Care
- BDN Real Estate
- Exchange
- IMTX Nasdaq
- BDN Nasdaq
- Market Cap
- IMTX 653.9M
- BDN 731.6M
- IPO Year
- IMTX N/A
- BDN N/A
- Fundamental
- Price
- IMTX $6.33
- BDN $4.03
- Analyst Decision
- IMTX Strong Buy
- BDN Hold
- Analyst Count
- IMTX 4
- BDN 1
- Target Price
- IMTX $14.67
- BDN $5.00
- AVG Volume (30 Days)
- IMTX 537.7K
- BDN 2.7M
- Earning Date
- IMTX 08-13-2025
- BDN 07-23-2025
- Dividend Yield
- IMTX N/A
- BDN 14.93%
- EPS Growth
- IMTX N/A
- BDN N/A
- EPS
- IMTX N/A
- BDN N/A
- Revenue
- IMTX $152,823,253.00
- BDN $306,596,000.00
- Revenue This Year
- IMTX N/A
- BDN $54.81
- Revenue Next Year
- IMTX $1.92
- BDN $2.93
- P/E Ratio
- IMTX N/A
- BDN N/A
- Revenue Growth
- IMTX 83.61
- BDN N/A
- 52 Week Low
- IMTX $3.30
- BDN $3.41
- 52 Week High
- IMTX $13.09
- BDN $6.54
- Technical
- Relative Strength Index (RSI)
- IMTX 52.73
- BDN 48.00
- Support Level
- IMTX $5.56
- BDN $3.83
- Resistance Level
- IMTX $6.50
- BDN $4.09
- Average True Range (ATR)
- IMTX 0.35
- BDN 0.12
- MACD
- IMTX -0.07
- BDN 0.01
- Stochastic Oscillator
- IMTX 62.10
- BDN 77.42
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.